Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

Imidazole containing drug with glutaminyl cyclase activity useful in

Full article: A patent review of glutaminyl cyclase inhibitors (2004–present)

Therapeutic potential of glutaminyl cyclases: Current status and emerging trends - ScienceDirect

Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design - ScienceDirect

Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design - ScienceDirect

An overview of glutaminyl cyclase inhibitors for Alzheimer's disease

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease—Studies on Relation to Effective Target Occupancy

The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease - Xu - 2019 - ChemistrySelect - Wiley Online Library

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease

Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents - ScienceDirect

Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design

Full article: Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias

RU2662559C1 - New inhibitor of glutaminyl cyclase and its use for treatment of lung and respiratory diseases - Google Patents

The First Potent Inhibitors for Human Glutaminyl Cyclase: Synthesis and Structure−Activity Relationship